.STUDY HIGHLIGHT.06 August 2024.
A sizable randomized measured test with cisgender ladies highlights the obstacles of obedience to a regular oral preexposure prophylaxis program and shows that twice-yearly shot of lenacapavir may keep effective HIV protection amounts over 6 months.